Total Payments
$273,723
2024 Payments
$44,489
Companies
58
Transactions
1,647
Medicare Patients
3,471
Medicare Billing
$618,956
Payment Breakdown by Category
Other$209,928 (76.7%)
Food & Beverage$23,281 (8.5%)
Travel$21,532 (7.9%)
Consulting$18,530 (6.8%)
Education$452.74 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200,908 | 93 | 73.4% |
| Food and Beverage | $23,281 | 1,458 | 8.5% |
| Travel and Lodging | $21,532 | 74 | 7.9% |
| Consulting Fee | $18,530 | 9 | 6.8% |
| Honoraria | $9,020 | 4 | 3.3% |
| Education | $452.74 | 9 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $93,106 | 516 | $0 (2024) |
| US WorldMeds, LLC | $44,828 | 112 | $0 (2020) |
| ACADIA Pharmaceuticals Inc | $42,326 | 70 | $0 (2024) |
| ABBVIE INC. | $40,170 | 209 | $0 (2024) |
| Acorda Therapeutics, Inc | $19,040 | 45 | $0 (2024) |
| MDD US Operations, LLC | $18,121 | 36 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $3,739 | 16 | $0 (2021) |
| UCB, Inc. | $2,237 | 55 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $1,727 | 130 | $0 (2023) |
| Abbott Laboratories | $1,054 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44,489 | 207 | Teva Pharmaceuticals USA, Inc. ($28,483) |
| 2023 | $31,902 | 189 | Teva Pharmaceuticals USA, Inc. ($18,953) |
| 2022 | $4,691 | 166 | Teva Pharmaceuticals USA, Inc. ($3,020) |
| 2021 | $18,863 | 202 | Teva Pharmaceuticals USA, Inc. ($7,440) |
| 2020 | $14,073 | 176 | AbbVie Inc. ($6,759) |
| 2019 | $46,012 | 199 | Acorda Therapeutics, Inc ($17,083) |
| 2018 | $66,284 | 273 | US WorldMeds, LLC ($25,470) |
| 2017 | $47,409 | 235 | ACADIA Pharmaceuticals Inc ($17,440) |
All Payment Transactions
1,647 individual payment records from CMS Open Payments — Page 1 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Merz Pharmaceuticals, LLC | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Parkinson's Disease | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 12/04/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 12/04/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: AMANTADINE | ||||||
| 11/20/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 11/19/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | Medtronic, Inc. | SENSIGHT (Device) | Food and Beverage | In-kind items and services | $39.54 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 11/07/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 11/06/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 11/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 11/05/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 879 | 12,825 | $447,804 | $159,985 |
| 2022 | 12 | 907 | 14,998 | $448,398 | $170,679 |
| 2021 | 13 | 860 | 15,676 | $442,548 | $156,841 |
| 2020 | 13 | 825 | 12,397 | $353,747 | $131,452 |
Total Patients
3,471
Total Services
55,896
Medicare Billing
$618,956
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 319 | 527 | $90,699 | $43,257 | 47.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 17 | 8,080 | $96,960 | $39,693 | 40.9% |
| J0586 | Injection, abobotulinumtoxina, 5 units | Office | 2023 | 11 | 3,551 | $94,457 | $23,292 | 24.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 120 | 192 | $22,080 | $11,432 | 51.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 100 | 101 | $40,905 | $10,051 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 116 | $12,904 | $7,518 | 58.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $17,955 | $6,656 | 37.1% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 15 | 48 | $28,781 | $6,638 | 23.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $16,800 | $3,719 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 30 | $7,500 | $2,986 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 25 | 25 | $7,125 | $2,543 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 15 | $2,580 | $1,118 | 43.3% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 15 | 21 | $3,738 | $766.20 | 20.5% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 17 | 28 | $5,320 | $316.80 | 6.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 26 | 13,760 | $165,120 | $64,219 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 295 | 475 | $81,700 | $42,232 | 51.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 131 | 210 | $24,150 | $11,343 | 47.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 93 | 93 | $37,665 | $9,326 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $18,810 | $7,858 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 63 | $15,750 | $7,750 | 49.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 46 | $27,600 | $6,978 | 25.3% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 18 | 53 | $22,362 | $4,942 | 22.1% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 11 | 37 | $19,425 | $3,832 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 33 | 33 | $9,405 | $3,417 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 29 | 36 | $6,192 | $2,664 | 43.0% |
About Dr. Katie Hendley, MD
Dr. Katie Hendley, MD is a Neurology healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2011. The National Provider Identifier (NPI) number assigned to this provider is 1831484831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katie Hendley, MD has received a total of $273,723 in payments from pharmaceutical and medical device companies, with $44,489 received in 2024. These payments were reported across 1,647 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($200,908).
As a Medicare-enrolled provider, Hendley has provided services to 3,471 Medicare beneficiaries, totaling 55,896 services with total Medicare billing of $618,956. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Lubbock, TX
- Active Since 06/17/2011
- Last Updated 09/08/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1831484831
Products in Payments
- AUSTEDO (Drug) $55,712
- NUPLAZID (Drug) $42,326
- Xadago (Drug) $40,739
- Austedo XR (Drug) $31,794
- DUOPA (Drug) $19,451
- Duopa (Drug) $18,905
- INBRIJA (Drug) $18,789
- Gocovri (Drug) $13,563
- GOCOVRI (Drug) $8,247
- SD809-HD (Drug) $3,738
- APOKYN (Drug) $3,489
- Neupro (Drug) $1,500
- UBRELVY (Drug) $1,042
- TROKENDI XR (Drug) $970.81
- Infinity DBS Pulse Generators (Device) $960.61
- AJOVY (Biological) $770.41
- PERCEPT PC BRAINSENSE (Device) $703.52
- OXTELLAR XR (Drug) $685.17
- QULIPTA (Drug) $543.59
- Briviact (Drug) $483.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lubbock
Henrik Wilms, Md, MD
Neurology — Payments: $137,644
Neurology $137,644
Bhupesh Dihenia, M.d, M.D
Neurology — Payments: $134,620
Neurology $134,620
Kalarickal Oommen, Md, MD
Neurology — Payments: $87,098
Neurology $87,098
Ahmad Sabouni, M.d, M.D
Neurology — Payments: $67,688
Neurology $67,688
Khondoker Alam, M.d, M.D
Neurology — Payments: $9,505
Neurology $9,505
Paul Brown, Md, MD
Neurology — Payments: $5,268
Neurology $5,268